ELAN FY 2024 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.4B+0.5% YoY

Gross Profit

$1.9B43.0% margin

Operating Income

$251M5.7% margin

Net Income

$338M7.6% margin

EPS (Diluted)

$0.68

Cash Flow

Operating Cash Flow

$541M

Free Cash Flow

$394M

Stock-Based Comp.

$55M

Balance Sheet

Total Assets

$12.6B

Total Liabilities

$6.5B

Stockholders' Equity

$6.1B

Cash & Equivalents

$468M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.4B	$4.4B	+0.5%
Gross Profit	$1.9B	$1.9B	-1.5%
Operating Income	$251M	$326M	-23.0%
Net Income	$338M	-$1.2B	+127.5%